Development and validation of a high-performance liquid chromatography method for the evaluation of niflumic acid cross-reactivity of two commercial immunoassays for cannabinoids in urine

Journal of Analytical Toxicology

Volumn 34, Issue 4, 2010, Pages 229-232

  Kovatsi, Leda ^a   Pouliopoulos, Athanasios ^a   Papadaki, Antonia ^a   Samanidou, Victoria ^a   Tsoukali, Heleni ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; NIFLUMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS REACTION; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FALSE POSITIVE RESULT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; KINETIC INTERACTION OF MICROPARTICLES IN A SOLUTION IMMUNOASSAY METHOD; SCREENING TEST; URINALYSIS; VALIDATION STUDY; CALIBRATION; COMPARATIVE STUDY; IMMUNOLOGY; LABORATORY DIAGNOSIS; METHODOLOGY; REPRODUCIBILITY; STATISTICAL PARAMETERS; SUBSTANCE ABUSE; URINE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALIBRATION; CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS REACTIONS; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; LIMIT OF DETECTION; NIFLUMIC ACID; PSYCHOTROPIC DRUGS; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE DETECTION;

EID: 77955501305     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.4.229     Document Type: Article

References (7)

1. A.R. Chase, P.R. Kelley, A. Taunton-Rigby, R.T. Jones, and T. Harwood. Quantitation of cannabinoids in biological fluids by radioimmunoassay. NIDA Res. Monogr. 7: 1-9 (1976).
2. D.L. Colbert. Drug abuse screening with immunoassays: unexpected cross-reactivities and other pitfalls. Br. J. Biomed. Sci. 51(2): 136-146 (1994).
3. 14C: absorption, excretion and biotransformation by human and dog. J. Pharmacol. Exp. Ther. 186: 323-330 (1973).
4. A.B. Jones, H.N. ElSohly, and M.A. ElSohly. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. V. Cross-reactivity of selected compounds in a radioimmunoassay. J. Anal. Toxicol. 8(6): 252-254 (1984).
5. M.A. ElSohly, A.B. Jones, and H.N. ElSohly. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay. J. Anal. Toxicol. 14(5): 277-279 (1990).
6. A.A. Piergies, S. Sainati, and B. Roth-Schechter. Lack of cross-reactivity of Ambien (zolpidem) with drugs in standard urine drug screens. Arch. Pathol. Lab. Med. 121(4): 392-394 (1997).
7. S. Rossi, T. Yaksh, H. Bentley, G. van den Brande, I. Grant, and R. Ellis. Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine. Clin. Chem. 52(5): 896-897 (2006).